tradingkey.logo
tradingkey.logo
Search

Quince Therapeutics Inc

QNCX
Add to Watchlist
33.000USD
-1.040-3.06%
Close 08-14 16:00ETQuotes delayed by 15 min
22.75MMarket Cap
1.46P/E TTM

QNCX Financials

See Quince Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Quince Therapeutics Inc Earnings Date

Latest Release
May 11, 2026
EPS / Forecast
36.00/-2.56
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-335.27
-2452.33%
Analyst Rating
BUY
2026/08/16
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
-258.10%-12.31
2402.35%78.75
-149.00%-7.09
-95.81%-2.49
46.57%-3.44
-31.95%-3.42
-31.59%-2.85
14.22%-1.27
-373.00%-6.43
-658.49%-2.59
-1295.65%-2.16
---1.48
---1.36
---0.34
---0.15
---1.41
----
----
----
----
Net Profit
----
338.94%35.91M
-216.73%-39.46M
-144.76%-13.44M
42.12%-16.05M
-34.81%-15.03M
-40.07%-12.46M
-2.64%-5.49M
-467.52%-27.73M
9.02%-11.15M
-60.72%-8.89M
32.45%-5.35M
70.50%-4.89M
43.38%-12.25M
76.35%-5.53M
63.51%-7.92M
23.86%-16.56M
6.26%-21.64M
-13.84%-23.40M
-0.93%-21.71M
Debt to assets ratio
-100.00%0.00%
-100.00%0.00%
54.07%19.27%
35.38%15.94%
41.27%14.49%
67.98%14.26%
56.41%12.51%
--11.78%
--10.26%
--8.49%
10835.48%8.00%
--0.00%
--0.00%
--0.00%
--0.07%
--0.09%
----
----
----
----
Operating profit
-706.29%-79.78M
24.84%-9.72M
-60.61%-16.24M
-32.97%-11.36M
-11.91%-9.89M
-49.13%-12.93M
-21.17%-10.11M
-40.24%-8.55M
-58.35%-8.84M
-22.92%-8.67M
-32.03%-8.34M
10.32%-6.09M
65.65%-5.58M
67.73%-7.06M
73.16%-6.32M
68.65%-6.79M
25.36%-16.26M
6.22%-21.86M
-12.91%-23.54M
1.07%-21.68M
Net Profit
----
338.94%35.91M
-216.73%-39.46M
-144.76%-13.44M
42.12%-16.05M
-34.81%-15.03M
-40.07%-12.46M
-2.64%-5.49M
-467.52%-27.73M
9.02%-11.15M
-60.72%-8.89M
32.45%-5.35M
70.50%-4.89M
43.38%-12.25M
76.35%-5.53M
63.51%-7.92M
23.86%-16.56M
6.26%-21.64M
-13.84%-23.40M
-0.93%-21.71M
Current assets
230.46%123.41M
-24.38%25.58M
-48.01%22.90M
-43.54%29.20M
-41.13%37.34M
-51.97%33.83M
-43.14%44.04M
-39.28%51.72M
-28.36%63.44M
-23.84%70.44M
-17.40%77.44M
-13.33%85.17M
-10.89%88.55M
-4.01%92.49M
-16.05%93.75M
-17.71%98.28M
-26.85%99.37M
-35.72%96.35M
-19.00%111.67M
-16.47%119.43M
Total current liabilities
13.83%8.50M
4.93%8.77M
493.93%43.23M
380.07%26.04M
-27.65%7.47M
-15.06%8.36M
-23.97%7.28M
140.79%5.42M
428.74%10.32M
215.83%9.84M
211.89%9.57M
-54.44%2.25M
-67.19%1.95M
-67.92%3.12M
-78.42%3.07M
-65.06%4.95M
-67.90%5.95M
-45.65%9.71M
-16.32%14.22M
-13.74%14.15M
Total assets
5.79%124.00M
-75.14%26.62M
-18.30%93.52M
-13.14%109.90M
-13.07%117.21M
-32.77%107.09M
-31.82%114.48M
48.17%126.52M
51.77%134.83M
70.70%159.29M
61.58%167.90M
-22.22%85.39M
-24.63%88.84M
-19.64%93.32M
-22.01%103.91M
-25.53%109.78M
-26.97%117.86M
-33.46%116.13M
-29.68%133.23M
-27.97%147.42M
Total liabilities
-85.30%15.51M
-87.63%10.95M
53.25%129.24M
33.40%108.84M
20.05%105.47M
3.99%88.51M
1.83%84.33M
3521.26%81.59M
4401.08%87.86M
2632.42%85.11M
2396.71%82.82M
-57.05%2.25M
-69.17%1.95M
-68.05%3.12M
-77.35%3.32M
-64.47%5.25M
-67.21%6.33M
-45.95%9.75M
-14.89%14.64M
-11.34%14.76M
Total equity
-400.99%-35.32M
-15.66%15.67M
-218.47%-35.71M
-97.64%1.06M
-75.01%11.74M
-74.95%18.58M
-64.57%30.15M
-45.95%44.93M
-45.94%46.97M
-17.77%74.18M
-15.42%85.08M
-20.47%83.13M
-22.10%86.88M
-15.21%90.20M
-15.17%100.59M
-21.20%104.53M
-21.50%111.53M
-32.02%106.38M
-31.16%118.59M
-29.44%132.65M
Net operating income
-65.46%-18.89M
20.56%-7.63M
-38.78%-10.48M
-36.75%-9.93M
-30.62%-11.41M
-14.94%-9.60M
-24.25%-7.55M
-50.68%-7.26M
-128.35%-8.74M
-134.04%-8.35M
-4.16%-6.08M
28.06%-4.82M
75.17%-3.83M
77.82%-3.57M
59.53%-5.83M
61.38%-6.70M
12.23%-15.41M
-18.23%-16.09M
-8.60%-14.42M
-40.18%-17.34M
Net investment
32.49%8.00M
10.11%12.00M
-25.73%8.07M
-125.07%-1.78M
221.31%6.04M
22.26%10.90M
101.61%10.87M
95.46%7.11M
75.51%-4.98M
60.90%8.91M
-71.12%5.39M
141.19%3.63M
-287.03%-20.32M
-58.70%5.54M
-10.77%18.67M
-1252.22%-8.83M
-193.37%-5.25M
-57.61%13.41M
32.18%20.92M
-92.61%766.00K
Net financing
655.85%108.93M
10754.02%9.44M
--2.03M
127.52%1.38M
41077.14%14.41M
-54.21%87.00K
-100.00%0.00
-50100.00%-5.00M
34.62%35.00K
280.00%190.00K
416.67%57.00K
300.00%10.00K
-75.93%26.00K
-91.96%50.00K
-101.82%-18.00K
-100.11%-5.00K
-83.93%108.00K
41.04%622.00K
2100.00%990.00K
5127.78%4.71M

FAQs

What are the current assets of Quince Therapeutics Inc?

According to Quince Therapeutics Inc's FY2025 earnings report, its current assets were 22.90M, with a year-on-year change of -48.01.

What are the total assets of Quince Therapeutics Inc?

According to Quince Therapeutics Inc's FY2025 earnings report, its total assets of Quince Therapeutics Inc were 93.52M, with a year-on-year change of -18.30.

What are the total liabilities of Quince Therapeutics Inc?

According to Quince Therapeutics Inc's FY2025 earnings report, its total liabilities of Quince Therapeutics Inc were 129.24M, with a year-on-year change of 53.25.

What is the total equity of Quince Therapeutics Inc?

According to Quince Therapeutics Inc's FY2025 earnings report, its total equity of Quince Therapeutics Inc was -35.71M, with a year-on-year change of -218.47.

What is the net operating income of Quince Therapeutics Inc?

According to Quince Therapeutics Inc's FY2025 earnings report, its net operating income of Quince Therapeutics Inc was -50.43M, with a year-on-year change of -39.42.

What is the net investment of Quince Therapeutics Inc?

According to Quince Therapeutics Inc's FY2025 earnings report, its net investment of Quince Therapeutics Inc was 23.23M, with a year-on-year change of 6.02.

What is the net financing of Quince Therapeutics Inc?

According to Quince Therapeutics Inc's FY2025 earnings report, its net financing of Quince Therapeutics Inc was 17.91M, with a year-on-year change of 475.06.

What is the Earnings Per Share (EPS) of Quince Therapeutics Inc?

According to Quince Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -335.27, with a year-on-year change of -2452.33.

What is the net income of Quince Therapeutics Inc?

According to Quince Therapeutics Inc's FY2025 earnings report, its net income was -83.98M, with a year-on-year change of -47.78.

What is the debt-to-asset ratio of Quince Therapeutics Inc?

According to Quince Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 19.27, with a year-on-year change of 54.07.

What is the Return on Assets (ROA) of Quince Therapeutics Inc?

According to Quince Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -80.75, with a year-on-year change of -100.62.

What is the operating profit of Quince Therapeutics Inc?

According to Quince Therapeutics Inc's FY2025 earnings report, its operating profit was -50.43M, with a year-on-year change of -39.42.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.